Nilai Buku saben Saham: BioCardia, Inc. (BCDA)

BioCardia, Inc. (BCDA) restores the heart through the innovative Helix system and stem cells. The book value per common share on the GURU.Markets chart confirms the trend, where the value 0.18 describes the current asset level. A team of elite cardiologists ensures scientific progress, which, upon successful completion of tests, will provide access to a colossal market for the therapy of severe pathologies.

Book value per share reflects the residual value of net assets attributable to a single security after deducting all liabilities, serving as a fundamental benchmark for the business's liquidation value. Analyzing the specific book value per share allows for an assessment of the financial stability of BioCardia, Inc. (BCDA) in the context of development costs for cell therapy delivery systems, confirming the real capitalization of its technological niche.